Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10648454

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V On Active Ingredients Medicines Vv 80

Deadline: 10 Aug 2026

Germany

Ref. No.: 10648263

EMD:Ref Document

Bid Value: Ref Document

188 Days Left

Open Framework Agreement On Drug Discounts According To Section 130A Paragraph 8 Of The Social Code Book V With The Possibility Of Joining At Any Time So Called Approval Model 2025 01

Deadline: 05 Nov 2026

Germany

Ref. No.: 10648209

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Dexamethasone Excluding Implant Obg Atc S01Ba01 For The Period 01 01 2025 31 12 2026

Deadline: 05 Nov 2026

Germany

Ref. No.: 10648194

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Open House Drug Discount Agreements Tocilizumab Atc L04Ac07

Deadline: 05 Nov 2026

Germany

Ref. No.: 10647784

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Open House Original Discount Contracts 2024 14 Bimatoprost Timolol Dosage Form Eye Drops As Single Dose Pipettes

Deadline: 31 Dec 2026

Germany

Ref. No.: 10647616

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Clindamycin Benzoyl Peroxide Obg Atc D10Af54 For The Period 01 01 2025 31 12 2026

Deadline: 05 Nov 2026

Germany

Ref. No.: 10647470

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Pyridostigmine Excluding Sustained Release Dafo Obg Atc N07Aa02 For The Period 01 01 2025 31 12 2026

Deadline: 05 Nov 2026

Germany

Ref. No.: 10647290

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Allergen Extract From Tree Pollen Exclusively In The Dafo Pump Solution Atc V01Aa05 For The Period

Deadline: 05 Nov 2026

Germany

Ref. No.: 10646918

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10641939

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Open House Drug Discount Agreements Lipegfilgrastim Atc L03Aa14

Deadline: 05 Nov 2026

Germany

Ref. No.: 10641838

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Rotigotine Obg Atc N04Bc09 For The Period 01 01 2025 31 12 2026

Deadline: 05 Nov 2026

Germany

Ref. No.: 10637096

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Sevelamer Hydrochloride Obg Atc V03Ae02 For The Period 01 01 2025 31 12 2026

Deadline: 05 Nov 2026

Germany

Ref. No.: 10632266

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Apremilast Obo Atc L04Aa32 For The Period 01 01 2025 31 12 2026

Deadline: 05 Nov 2026

Germany

Ref. No.: 10631330

EMD:Ref Document

Bid Value: Ref Document

275 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10628137

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!